Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › methicillin-resistant Staphylococcus aureus (MRSA)

Methicillin-resistant Staphylococcus aureus (MRSA)

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for methicillin-resistant Staphylococcus aureus (MRSA)

3 trials tracked for methicillin-resistant Staphylococcus aureus (MRSA): 2 in phase 3 or 4.

3Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Other / NA 1
  1. Phase 4 Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) Completed
  2. Phase 4 Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) Completed
  3. N/A Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Narrative review discusses CRISPR strategies for MRSA biofilm infections with noted limitations
Infectious Disease Sys. Review
Narrative review discusses CRISPR strategies for MRSA biofilm infections with noted limitations CRISPR could outsmart stubborn staph infections hiding in biofilms
This narrative review examines CRISPR-based strategies targeting resistance genes and virulence factors in Methicillin-resistant Staphylococ…
New CRISPR-based strategies may help break down the protective slime that lets MRSA survive antibiotics, offering hope for hard-to-treat inf…
Frontiers May 13, 2026
Vancomycin AUC24 Monitoring Correlates With Trough Levels in Pediatric MRSA Inpatients: A Prospective Multicenter Study
Drug Pipeline Cohort
Vancomycin AUC24 Monitoring Correlates With Trough Levels in Pediatric MRSA Inpatients: A Prospective Multicenter Study Better Vancomycin Dosing Could Protect Children’s Kidneys
This prospective multicenter cohort study included 70 pediatric inpatients with methicillin-resistant Staphylococcus aureus (MRSA).
A new way to measure antibiotic levels in children may prevent kidney damage while fighting infection.
Frontiers Apr 19, 2026
Mini-review examines MRSA-influenza co-infection pathogenesis and adjunctive therapies
Emergency Medicine Sys. Review
Mini-review examines MRSA-influenza co-infection pathogenesis and adjunctive therapies Flu Damage Lets Bacteria Destroy Your Lungs
A mini-review examines the pathogenesis of MRSA-influenza co-infection, noting influenza damages respiratory epithelium and facilitates S.
Flu damage breaks your lung's protective shield, letting bacteria multiply and destroy healthy tissue to cause severe pneumonia.
Frontiers Apr 11, 2026